citrulline has been researched along with Chronic Progressive Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, MW; Kovalchuk, O; Metz, LM | 1 |
| Cao, L; Kalbacher, H; Ling, NC; Martin, RM; Tranquill, LR; Whitaker, JN | 1 |
1 review(s) available for citrulline and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Epigenetic changes in patients with multiple sclerosis.
Topics: Citrulline; Disease Progression; DNA Methylation; Epigenesis, Genetic; Forecasting; Gene-Environment Interaction; Histone Deacetylase Inhibitors; Humans; Inflammation Mediators; Lymphocyte Activation; Macrophage Activation; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Neurotransmitter Agents; Oligonucleotides; Risk Factors; T-Lymphocytes, Helper-Inducer | 2013 |
1 other study(ies) available for citrulline and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients.
Topics: Adult; Cell Line; Citrulline; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Peptide Fragments; Reference Values; T-Lymphocytes | 2000 |